Sysmex Europe
Menu

December - Emulsion PCR for highly sensitive detection of tumour mutations in peripheral blood

The BEAMing technology involves conversion of single DNA molecules to single magnetic beads, each containing thousands of copies of the sequence of the original DNA molecule. The number of variant DNA molecules in the population can be assessed by staining the beads with fluorescent probes and counting them by using flow cytometry. This way OncoBEAM® blood-based tests deliver a minimally invasive alternative for sensitive real-time molecular diagnostics to improve cancer characterisation and treatment.

Copyright © Sysmex Europe GmbH. All rights reserved.

Cookie-Settings

We use cookies to enable you to optimally use our website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.

By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.

are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.